Brief: Autolus Therapeutics Reports Q2 2022 Financial Results
04/08/2022 12:35
Aug 4 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND OPERATIONAL PROGRESS
* AUTOLUS THERAPEUTICS PLC - QTRLY LOSS PER SHARE $0.46
Source text for Eikon: ID:nGNX264shd
Further company coverage: AUTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants